Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-23T09:19:49.506Z Has data issue: false hasContentIssue false
  • English
  • Français

Thirty-Day Laboratory-Based Surveillance for Carbapenem-Resistant Enterobacteriaceae in the Minneapolis-St. Paul Metropolitan Area

Published online by Cambridge University Press:  10 May 2016

Edwin C. Pereira ,
Kristin M. Shaw ,
Paula M. Snippes Vagnone ,
Jane E. Harper ,
Alexander J. Kallen ,
Brandi M. Limbago  and
Ruth Lynfield
Edwin C. Pereira*
Affiliation:
Division of Infectious Diseases and International Medicine; , University of Minnesota, Minneapolis, Minnesota
Kristin M. Shaw
Affiliation:
Minnesota Department of Health, St. Paul, Minnesota
Paula M. Snippes Vagnone
Affiliation:
Minnesota Department of Health, St. Paul, Minnesota
Jane E. Harper
Affiliation:
Minnesota Department of Health, St. Paul, Minnesota
Alexander J. Kallen
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Brandi M. Limbago
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Ruth Lynfield
Affiliation:
Minnesota Department of Health, St. Paul, Minnesota
*
420 Delaware Street SE, MMC 250, Minneapolis, MN 55455 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Carbapenem-resistant Enterobacteriaceae (CRE) are a growing problem in the United States. We explored the feasibility of active laboratory-based surveillance of CRE in a metropolitan area not previously considered to be an area of CRE endemicity. We provide a framework to address CRE surveillance and to monitor changes in the incidence of CRE infection over time.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 4: Special Topic Issue: Carbapenem-Resistant Enterobacteriaceae and Multidrug-Resistant Organisms , April 2014 , pp. 423 - 425
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Centers for Disease Control and Prevention. Healthcare-associated infections (HAIs): tracking CRE. http://www.cdc.gov/hai/organisms/cre/TrackingCRE.html. Published luly 9, 2012. Accessed June 28, 2013.Google Scholar
2. Gupta, N, Limbago, BM, Patel, JB, Kallen, AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011;53(1):60–67.Google Scholar
3. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Second Informational Supplement. Wayne, PA: CLSI, 2012. CLSI document M100-S22.Google Scholar
4. Centers for Disease Control and Prevention. Healthcare-associated infections (HAIs): multiplex real-time PCR detection of Klebsiella pneumoniae carbapenemase (KPC) and New Delhi metallo-β-lactamase (NDM-1) genes. http://www.cdc.gov/HAI/settings/lab/kpc-ndml-lab-protocol.html. Updated April 20, 2011. Accessed January 30, 2013.Google Scholar